A study by the Università Cattolica, Rome campus - Fondazione Policlinico Universitario A. Gemelli IRCCS and the Ospedale Pediatrico Bambino Gesù IRCCS, published in the Nature Group journal ‘Pediatric Research’, identifies the ‘protein signature’ of the condition in plasma, a group of pro-inflammatory molecules present at high concentrations in young patients with the condition. An Artificial Intelligence (AI) tool makes the diagnosis based on the results of the blood sample.

While child deaths in England fell temporarily during the COVID-19 pandemic, they have now risen to new heights, a new study from researchers at the University of Bristol and based on unique National Child Mortality Database (NCMD) data has found.

A new experimental vaccine could offer protection not only against many variants of SARS-CoV-2, but also other sarbecoviruses that could spill over from animals to humans.

Investigators from Mass General Brigham have found that a method originally designed for cancer detection can also identify and monitor even tiny amounts of SARS-CoV-2 intact viral particles in blood and other fluids from patients with acute COVID-19 infections, creating the potential for guiding future treatment of patients. The research is published in Science Advances.

With lawmakers in Washington, D.C. and state houses getting ready to make major health policy decisions, a pair of new University of Michigan studies shows how past policy decisions have affected older Americans with modest or low incomes. The new findings could also help inform upcoming decisions about health insurance programs that are currently open to people with incomes under about $60,000 per person, and programs aimed at those living in or near poverty.